Trading Ideas

Warren Buffett famously said, ‘Volatility is far from synonymous with risk.’ So it might be obvious that you need to… …read more […]

Zedge, Inc. (NYSEMKT:ZDGE) defied analyst predictions to release its yearly results, which were ahead of market… …read more […]

(Bloomberg) — Hasbro Inc. slipped in early trading after reporting third-quarter sales that didn’t wow investors as much as rival Mattel Inc.’s results did last week.Hasbro, the largest U.S. toymaker, said Monday that revenue fell 4% on a pro forma basis to $1.78 billion. That beat analysts’ predictions of $1.74 billion. Excluding Entertainment One, which Hasbro acquired earlier this year, revenue rose 13%. Adjusted profit was $1.88 a share, topping estimates of $1.60, led by its games segment.Still, Hasbro shares fell as much as 4.1% to $88.25 in premarket trading as traders focused on the contrast with Mattel.While both companies …read more […]

Timothy P. Lynch’s Stonepine Capital is a life science-focused hedge fund that seeks to utilize its industry experience to uncover undervalued and under-the-radar health companies. The fund takes a long-term approach to its small number of investments, which are focused on companies that have successfully commercialized products and which are in a strong financial position. […] …read more […]

Some investors rely on dividends for growing their wealth, and if you’re one of those dividend sleuths, you might be… …read more […]

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will… …read more […]

Stock futures pointed sharply lower Monday morning as new data showed a jump in COVID-19 cases in both the U.S. and Europe. Restrictions tightened across major countries overseas, raising the specter of a further pullback in business operations and deeper anchor on global economic activity. …read more […]

Those following along with Selecta Biosciences, Inc. (NASDAQ:SELB) will no doubt be intrigued by the recent purchase… …read more […]

(Bloomberg) — Libya is set to restart the last of its major oil fields following a ceasefire in its civil war, a milestone for the OPEC member that’s been largely offline since January.Oil dropped after the state energy firm lifted force majeure on exports from El Feel on Monday. The move will bolster the Tripoli-based National Oil Corp.’s attempt to boost Libyan production to 1 million barrels each day within a month.The return of Libyan barrels is hindering OPEC+ as it tries to prop up crude prices amid a resurgence in coronavirus cases and with many major economies imposing lockdowns …read more […]

The last three months have been tough on Altimmune, Inc. (NASDAQ:ALT) shareholders, who have seen the share price… …read more […]

Citigroup Inc. (NYSE:C) stock is about to trade ex-dividend in three days. Ex-dividend means that investors that… …read more […]

(Bloomberg Opinion) — Heading into last Friday, there was no shortage of superlatives to describe the rise in long-term yields in the $20.4 trillion U.S. Treasury market. Just to name a few:The yield curve from five to 30 years steepened to 130 basis points, the widest gap since Nov. 16, 2016. The benchmark 10-year Treasury yield had climbed for six consecutive trading sessions, the longest stretch since September 2019. At 0.868%, the 10-year yield reached its highest level in more than four months and briefly broke above its 200-day moving average from below for the first time since late 2017. …read more […]

Top news and what to watch in the markets on Monday, October 26, 2020. …read more […]

(Bloomberg) — Bayer AG agreed to acquire U.S. biotech company Asklepios BioPharmaceutical Inc. for as much as $4 billion, bolstering its pharma division with experimental gene therapies before patents expire on some key drugs.The German chemicals giant will pay $2 billion upfront and another $2 billion in potential milestone payments in cash for closely held AskBio, a North Carolina-based company that’s developing gene therapies for ailments such as Parkinson’s disease and congestive heart failure.Bayer is expanding in the cutting-edge field of gene and cell therapies at a time when its blockbuster drugs age and the company’s crop-protection business reels from …read more […]

(Bloomberg) — Coca-Cola European Partners Plc agreed to buy Australian bottler Coca-Cola Amatil Ltd., creating a global producer of packaged beverages to better withstand a slowdown in the industry and the shift away from sugary drinks.The purchase values Sydney-based Coca-Cola Amatil at A$9.23 billion ($6.6 billion), a 19% premium to where its shares traded last week. The target’s board intends to unanimously recommend the offer.The A$12.75-per-share cash deal would double the European company’s potential market at a stroke, putting almost 300 million consumers within reach in the Southern Hemisphere, including the key developing nation of Indonesia.Such growth opportunities are all …read more […]